TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs7772160
log Bayes Factor = 39.6129
Chromosome 6   position 27,412,386  (GRCh37) Explore rs7772160 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
K90.0 Coeliac disease
1.000 0.000 0.000
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.000 0.204 0.796
K90 Intestinal malabsorption
0.714 0.286 0.000
K40 Inguinal hernia
0.000 0.353 0.647
K90.9 Intestinal malabsorption, unspecified
0.641 0.359 0.000
K40.2 Bilateral inguinal hernia, without obstruction or gangrene
0.000 0.405 0.595
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.572 0.428 0.000
K40.4 Unilateral or unspecified inguinal hernia, with gangrene
0.000 0.471 0.529
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene
0.000 0.485 0.515
K90.3 Pancreatic steatorrhoea
0.512 0.488 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.512 0.488 0.000
K90.1 Tropical sprue
0.512 0.488 0.000
K90.8 Other intestinal malabsorption
0.472 0.528 0.000
K40.1 Bilateral inguinal hernia, with gangrene
0.000 0.536 0.464
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
0.000 0.591 0.409
E05.9 Thyrotoxicosis, unspecified
0.220 0.780 0.000
E03.9 Hypothyroidism, unspecified
0.114 0.886 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.102 0.898 0.000
K76.8 Other specified diseases of liver
0.000 0.901 0.099
E03 Other hypothyroidism
0.086 0.914 0.000
E00-E07 Disorders of thyroid gland
0.080 0.920 0.000
M25.57 Pain in joint (Ankle and foot)
0.000 0.920 0.080
E83 Disorders of mineral metabolism
0.000 0.925 0.075
E05.5 Thyroid crisis or storm
0.073 0.927 0.000
E05.4 Thyrotoxicosis factitia
0.073 0.927 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.073 0.927 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.073 0.927 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.064 0.936 0.000
E03.5 Myxoedema coma
0.062 0.938 0.000
E03.4 Atrophy of thyroid (acquired)
0.062 0.938 0.000
E03.3 Postinfectious hypothyroidism
0.062 0.938 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.062 0.938 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.060 0.940 0.000
E05.8 Other thyrotoxicosis
0.058 0.941 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.058 0.942 0.000
E00 Congenital iodine-deficiency syndrome
0.058 0.942 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.057 0.943 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.944 0.056
E83.8 Other disorders of mineral metabolism
0.000 0.946 0.054
E83.2 Disorders of zinc metabolism
0.000 0.946 0.054
E83.0 Disorders of copper metabolism
0.000 0.946 0.054
E03.1 Congenital hypothyroidism without goitre
0.052 0.948 0.000
E83.3 Disorders of phosphorus metabolism
0.000 0.952 0.048
E03.8 Other specified hypothyroidism
0.048 0.952 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.046 0.954 0.000
E06 Thyroiditis
0.043 0.957 0.000
K90-K93 Other diseases of the digestive system
0.042 0.958 0.000
E07 Other disorders of thyroid
0.042 0.958 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.041 0.958 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.041 0.958 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.041 0.958 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.041 0.958 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.041 0.958 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.041 0.958 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.041 0.958 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.041 0.958 0.000
M25.5 Pain in joint
0.000 0.963 0.037
M25.55 Pain in joint (Pelvic region and thigh)
0.000 0.963 0.037
E06.9 Thyroiditis, unspecified
0.032 0.967 0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation
0.000 0.968 0.032
J06.9 Acute upper respiratory infection, unspecified
0.000 0.968 0.032
E06.4 Drug-induced thyroiditis
0.031 0.969 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.031 0.969 0.000
E06.1 Subacute thyroiditis
0.031 0.969 0.000
E06.0 Acute thyroiditis
0.031 0.969 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.031 0.969 0.000
E07.1 Dyshormogenetic goitre
0.030 0.970 0.000
E07.0 Hypersecretion of calcitonin
0.030 0.970 0.000
K40-K46 Hernia
0.000 0.970 0.030
M25.52 Pain in joint (Upper arm)
0.000 0.970 0.030
E07.8 Other specified disorders of thyroid
0.029 0.971 0.000
M25.53 Pain in joint (Forearm)
0.000 0.971 0.029
M25.58 Pain in joint (Other)
0.000 0.972 0.028
M25.51 Pain in joint (Shoulder region)
0.000 0.973 0.027
E06.5 Other chronic thyroiditis
0.027 0.973 0.000
K44 Diaphragmatic hernia
0.000 0.977 0.023
M25.54 Pain in joint (Hand)
0.000 0.977 0.023
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere
0.022 0.978 0.000
K93.1 Megacolon in Chagas' disease
0.022 0.978 0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands
0.022 0.978 0.000
M20.1 Hallux valgus (acquired)
0.000 0.979 0.021
K44.0 Diaphragmatic hernia with obstruction, without gangrene
0.000 0.979 0.021
E06.3 Autoimmune thyroiditis
0.020 0.980 0.000
M47.99 Spondylosis, unspecified (Site unspecified)
0.000 0.981 0.019
K45 Other abdominal hernia
0.000 0.981 0.019
M20.6 Acquired deformity of toe(s), unspecified
0.000 0.982 0.018
M20.4 Other hammer toe(s) (acquired)
0.000 0.982 0.018
E83.4 Disorders of magnesium metabolism
0.000 0.982 0.018
M20 Acquired deformities of fingers and toes
0.000 0.982 0.018
M25.59 Pain in joint (Site unspecified)
0.000 0.982 0.018
K46 Unspecified abdominal hernia
0.000 0.983 0.017
M25.50 Pain in joint (Multiple sites)
0.000 0.983 0.017
M20.5 Other deformities of toe(s) (acquired)
0.000 0.983 0.017
E07.9 Disorder of thyroid, unspecified
0.016 0.983 0.000
K44.1 Diaphragmatic hernia with gangrene
0.000 0.984 0.016
L72.0 Epidermal cyst
0.000 0.984 0.016
K41 Femoral hernia
0.000 0.986 0.014
K44.9 Diaphragmatic hernia without obstruction or gangrene
0.000 0.986 0.014
J06 Acute upper respiratory infections of multiple and unspecified sites
0.000 0.986 0.014
K45.1 Other specified abdominal hernia with gangrene
0.000 0.986 0.013
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.987 0.013
L72 Follicular cysts of skin and subcutaneous tissue
0.000 0.987 0.013
K46.1 Unspecified abdominal hernia with gangrene
0.000 0.987 0.013
K42 Umbilical hernia
0.000 0.988 0.012
K45.0 Other specified abdominal hernia with obstruction, without gangrene
0.000 0.988 0.012
K45.8 Other specified abdominal hernia without obstruction or gangrene
0.000 0.988 0.012
E88 Other metabolic disorders
0.000 0.988 0.012
L72.1 Trichilemmal cyst
0.000 0.988 0.012
L72.9 Follicular cyst of skin and subcutaneous tissue, unspecified
0.000 0.988 0.012
K41.4 Unilateral or unspecified femoral hernia, with gangrene
0.000 0.989 0.011
K46.9 Unspecified abdominal hernia without obstruction or gangrene
0.000 0.989 0.011
K43 Ventral hernia
0.000 0.989 0.011
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene
0.000 0.989 0.011
K41.1 Bilateral femoral hernia, with gangrene
0.000 0.989 0.010
K41.0 Bilateral femoral hernia, with obstruction, without gangrene
0.000 0.989 0.010
K46.0 Unspecified abdominal hernia with obstruction, without gangrene
0.000 0.989 0.010
L72.8 Other follicular cysts of skin and subcutaneous tissue
0.000 0.990 0.010
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.990 0.010
J06.8 Other acute upper respiratory infections of multiple sites
0.000 0.990 0.010
J06.0 Acute laryngopharyngitis
0.000 0.990 0.010
E88.3 Tumour lysis syndrome
0.000 0.990 0.010
E88.8 Other specified metabolic disorders
0.000 0.990 0.010
K41.2 Bilateral femoral hernia, without obstruction or gangrene
0.000 0.990 0.010
M20.0 Deformity of finger(s)
0.000 0.990 0.010
L72.2 Steatocystoma multiplex
0.000 0.990 0.010
N02.9 Unspecified
0.000 0.991 0.009
K42.1 Umbilical hernia with gangrene
0.000 0.991 0.009
I26.9 Pulmonary embolism without mention of acute cor pulmonale
0.000 0.991 0.009
E88.2 Lipomatosis, not elsewhere classified
0.000 0.991 0.009
K42.0 Umbilical hernia with obstruction, without gangrene
0.000 0.991 0.009
E70-E90 Metabolic disorders
0.000 0.991 0.009
K43.1 Ventral hernia with gangrene
0.000 0.992 0.008
K43.7 Other and unspecified ventral hernia with gangrene
0.000 0.992 0.008
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene
0.000 0.992 0.008
K43.5 Parastomal hernia without obstruction or gangrene
0.000 0.992 0.008
K43.4 Parastomal hernia with gangrene
0.000 0.992 0.008
K43.3 Parastomal hernia with obstruction, without gangrene
0.000 0.992 0.008
K43.2 Incisional hernia without obstruction or gangrene
0.000 0.992 0.008
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.992 0.008
E88.9 Metabolic disorder, unspecified
0.000 0.992 0.008
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.992 0.008
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.992 0.008
G63.2 Diabetic polyneuropathy
0.000 0.993 0.007
T40.2 Other opioids
0.000 0.993 0.007
E85 Amyloidosis
0.000 0.993 0.007
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand
0.007 0.993 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.993 0.007
E80.1 Porphyria cutanea tarda
0.000 0.993 0.007
E80.4 Gilbert's syndrome
0.000 0.993 0.007
E85.9 Amyloidosis, unspecified
0.000 0.993 0.007
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.993 0.007
K43.0 Ventral hernia with obstruction, without gangrene
0.000 0.993 0.007
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.993 0.007
T39.1 4-Aminophenol derivatives
0.000 0.993 0.007
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.994 0.006
E72 Other disorders of amino-acid metabolism
0.000 0.994 0.006
T50.8 Diagnostic agents
0.000 0.994 0.006
E77 Disorders of glycoprotein metabolism
0.000 0.994 0.006
E76 Disorders of glycosaminoglycan metabolism
0.000 0.994 0.006
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.994 0.006
E70 Disorders of aromatic amino-acid metabolism
0.000 0.994 0.006
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.994 0.006
T42.4 Benzodiazepines
0.000 0.994 0.006
G95.8 Other specified diseases of spinal cord
0.000 0.994 0.006
I26 Pulmonary embolism
0.000 0.994 0.006
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.994 0.006
L43.9 Lichen planus, unspecified
0.006 0.994 0.000
G54.9 Nerve root and plexus disorder, unspecified
0.006 0.994 0.000
T50.4 Drugs affecting uric acid metabolism
0.000 0.994 0.006
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.994 0.006
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.994 0.006
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.994 0.006
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.994 0.006
E84 Cystic fibrosis
0.000 0.994 0.006
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.994 0.006
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.994 0.006
E80.5 Crigler-Najjar syndrome
0.000 0.994 0.006
E80.3 Defects of catalase and peroxydase
0.000 0.994 0.006
E80.0 Hereditary erythropoietic porphyria
0.000 0.994 0.006
E80.6 Other disorders of bilirubin metabolism
0.000 0.994 0.006
K50.0 Crohn's disease of small intestine
0.000 0.994 0.006
G31.9 Degenerative disease of nervous system, unspecified
0.000 0.994 0.006
R27.0 Ataxia, unspecified
0.000 0.994 0.006
T50.7 Analeptics and opioid receptor antagonists
0.000 0.994 0.006
T50.5 Appetite depressants
0.000 0.994 0.006
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.994 0.006
T50.1 Loop [high-ceiling] diuretics
0.000 0.994 0.006
T50.0 Mineralocorticoids and their antagonists
0.000 0.994 0.006
I26.0 Pulmonary embolism with mention of acute cor pulmonale
0.000 0.994 0.006
E80.2 Other porphyria
0.000 0.994 0.006
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.994 0.006
E79 Disorders of purine and pyrimidine metabolism
0.000 0.994 0.006
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.994 0.006
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.994 0.006
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.994 0.005
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.994 0.005
E85.8 Other amyloidosis
0.000 0.995 0.005
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.995 0.005
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.995 0.005
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.995 0.005
E85.3 Secondary systemic amyloidosis
0.000 0.995 0.005
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.995 0.005
G44.2 Tension-type headache
0.005 0.995 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.995 0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.995 0.005
T40.1 Heroin
0.000 0.995 0.005
T40.5 Cocaine
0.000 0.995 0.005
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.995 0.005
G31.8 Other specified degenerative diseases of nervous system
0.000 0.995 0.005
G31 Other degenerative diseases of nervous system, not elsewhere classified
0.000 0.995 0.005
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.995 0.005
T40.8 Lysergide [LSD]
0.000 0.995 0.005
T40.7 Cannabis (derivatives)
0.000 0.995 0.005
T40.3 Methadone
0.000 0.995 0.005
T40.0 Opium
0.000 0.995 0.005
M20.3 Other deformity of hallux (acquired)
0.000 0.995 0.005
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.995 0.005
G30 Alzheimer's disease
0.000 0.995 0.005
G95.9 Disease of spinal cord, unspecified
0.000 0.995 0.005
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.995 0.005
I71.2 Thoracic aortic aneurysm, without mention of rupture
0.000 0.995 0.005
K75.4 Autoimmune hepatitis
0.005 0.995 0.000
E72.0 Disorders of amino-acid transport
0.000 0.995 0.005
G30.0 Alzheimer's disease with early onset
0.000 0.995 0.005
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.995 0.005
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.995 0.005
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.995 0.005
E72.5 Disorders of glycine metabolism
0.000 0.995 0.005
E72.4 Disorders of ornithine metabolism
0.000 0.995 0.005
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.995 0.005
E72.2 Disorders of urea cycle metabolism
0.000 0.995 0.005
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.995 0.005
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.995 0.005
T42.0 Hydantoin derivatives
0.000 0.995 0.005
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.995 0.005
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.995 0.005
E70.3 Albinism
0.000 0.995 0.005
E70.2 Disorders of tyrosine metabolism
0.000 0.995 0.005
E70.1 Other hyperphenylalaninaemias
0.000 0.995 0.005
E70.0 Classical phenylketonuria
0.000 0.995 0.005
E71.3 Disorders of fatty-acid metabolism
0.000 0.995 0.005
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.995 0.005
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.995 0.005
E71.0 Maple-syrup-urine disease
0.000 0.995 0.005
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.995 0.005
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.995 0.005
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.995 0.005
E76.2 Other mucopolysaccharidoses
0.000 0.995 0.005
E76.1 Mucopolysaccharidosis, type II
0.000 0.995 0.005
E76.0 Mucopolysaccharidosis, type I
0.000 0.995 0.005
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.995 0.005
E77.8 Other disorders of glycoprotein metabolism
0.000 0.995 0.005
E77.1 Defects in glycoprotein degradation
0.000 0.995 0.005
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.995 0.005
T36 Poisoning by systemic antibiotics
0.000 0.995 0.005
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.995 0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.995 0.005
E73 Lactose intolerance
0.000 0.995 0.004
T39.4 Antirheumatics, not elsewhere classified
0.000 0.995 0.005
T39.2 Pyrazolone derivatives
0.000 0.995 0.005
E74 Other disorders of carbohydrate metabolism
0.000 0.995 0.005
T43.9 Psychotropic drug, unspecified
0.000 0.995 0.005
E85.4 Organ-limited amyloidosis
0.000 0.995 0.005
R27.8 Other and unspecified lack of coordination
0.000 0.995 0.005
T38.9 Other and unspecified hormone antagonists
0.000 0.995 0.005
T38.7 Androgens and anabolic congeners
0.000 0.995 0.005
T38.5 Other oestrogens and progestogens
0.000 0.995 0.005
T38.4 Oral contraceptives
0.000 0.995 0.005
T38.2 Antithyroid drugs
0.000 0.995 0.005
T38.0 Glucocorticoids and synthetic analogues
0.000 0.995 0.005
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.995 0.004
T37.5 Antiviral drugs
0.000 0.995 0.004
T37.4 Anthelminthics
0.000 0.995 0.004
T37.3 Other antiprotozoal drugs
0.000 0.995 0.004
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.995 0.004
T37.1 Antimycobacterial drugs
0.000 0.995 0.004
T37.0 Sulphonamides
0.000 0.995 0.004
E84.9 Cystic fibrosis, unspecified
0.000 0.995 0.004
T40.6 Other and unspecified narcotics
0.000 0.995 0.005
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.995 0.005
G30.9 Alzheimer's disease, unspecified
0.000 0.995 0.005
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.995 0.005
G95 Other diseases of spinal cord
0.000 0.995 0.005
N02 Recurrent and persistent haematuria
0.000 0.995 0.005
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.995 0.005
T42.2 Succinimides and oxazolidinediones
0.000 0.995 0.005
S62.50 Fracture of thumb (closed)
0.005 0.995 0.000
E84.8 Cystic fibrosis with other manifestations
0.000 0.995 0.004
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.995 0.004
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.995 0.004
E75.6 Lipid storage disorder, unspecified
0.000 0.995 0.004
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.995 0.004
E75.3 Sphingolipidosis, unspecified
0.000 0.995 0.004
E75.2 Other sphingolipidosis
0.000 0.995 0.004
E75.1 Other gangliosidosis
0.000 0.995 0.004
E75.0 GM2 gangliosidosis
0.000 0.995 0.004
T47.2 Stimulant laxatives
0.000 0.995 0.004
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)
0.005 0.995 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.995 0.004
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.995 0.004
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.996 0.004
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.996 0.004
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.996 0.004
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.996 0.004
E79.1 Lesch-Nyhan syndrome
0.000 0.996 0.004
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.996 0.004
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.996 0.004
T47.7 Emetics
0.000 0.996 0.004
T47.6 Antidiarrhoeal drugs
0.000 0.996 0.004
T47.5 Digestants
0.000 0.996 0.004
T47.3 Saline and osmotic laxatives
0.000 0.996 0.004
R27 Other lack of coordination
0.000 0.996 0.004
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.996 0.004
T48.5 Anti-common-cold drugs
0.000 0.996 0.004
T48.4 Expectorants
0.000 0.996 0.004
T48.3 Antitussives
0.000 0.996 0.004
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.996 0.004
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.996 0.004
T48.0 Oxytocic drugs
0.000 0.996 0.004
G24.9 Dystonia, unspecified
0.000 0.996 0.004
G30.8 Other Alzheimer's disease
0.000 0.996 0.004
M72.0 Palmar fascial fibromatosis [Dupuytren]
0.004 0.996 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.996 0.004
S62.51 Fracture of thumb (open)
0.004 0.996 0.000
T42.3 Barbiturates
0.000 0.996 0.004
M94.86 Other specified disorders of cartilage (Lower leg)
0.004 0.996 0.000
G30-G32 Other degenerative diseases of the nervous system
0.000 0.996 0.004
T47.0 Histamine H(2)-receptor antagonists
0.000 0.996 0.004
T49.9 Topical agent, unspecified
0.000 0.996 0.004
T49.8 Other topical agents
0.000 0.996 0.004
T49.7 Dental drugs, topically applied
0.000 0.996 0.004
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.996 0.004
T49.5 Ophthalmological drugs and preparations
0.000 0.996 0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.996 0.004
T49.3 Emollients, demulcents and protectants
0.000 0.996 0.004
T49.2 Local astringents and local detergents
0.000 0.996 0.004
T49.1 Antipruritics
0.000 0.996 0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.996 0.004
E75.5 Other lipid storage disorders
0.000 0.996 0.004
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.996 0.004
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.996 0.004
T45.8 Other primarily systemic and haematological agents
0.000 0.996 0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.996 0.004
T45.6 Fibrinolysis-affecting drugs
0.000 0.996 0.004
T45.4 Iron and its compounds
0.000 0.996 0.004
T45.3 Enzymes, not elsewhere classified
0.000 0.996 0.004
D73.8 Other diseases of spleen
0.000 0.996 0.004
T42.1 Iminostilbenes
0.000 0.996 0.004
N02.8 Other
0.000 0.996 0.004
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.996 0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.996 0.004
E04 Other non-toxic goitre
0.004 0.996 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.996 0.004
T41.5 Therapeutic gases
0.000 0.996 0.004
T41.4 Anaesthetic, unspecified
0.000 0.996 0.004
T41.3 Local anaesthetics
0.000 0.996 0.004
T41.1 Intravenous anaesthetics
0.000 0.996 0.004
T41.0 Inhaled anaesthetics
0.000 0.996 0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.996 0.004
G30.1 Alzheimer's disease with late onset
0.000 0.996 0.004
D75.8 Other specified diseases of blood and blood-forming organs
0.000 0.996 0.004
G31.1 Senile degeneration of brain, not elsewhere classified
0.000 0.996 0.004
G95.0 Syringomyelia and syringobulbia
0.000 0.996 0.004
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.996 0.004
T47.4 Other laxatives
0.000 0.996 0.004
T36.4 Tetracyclines
0.000 0.996 0.004
T36.3 Macrolides
0.000 0.996 0.004
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.996 0.004
T39.0 Salicylates
0.000 0.996 0.004
G24.3 Spasmodic torticollis
0.000 0.996 0.004
T43.6 Psychostimulants with abuse potential
0.000 0.996 0.004
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.996 0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.996 0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.996 0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.996 0.004
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.996 0.004
T44.0 Anticholinesterase agents
0.000 0.996 0.004
T36.9 Systemic antibiotic, unspecified
0.000 0.996 0.004
T36.8 Other systemic antibiotics
0.000 0.996 0.004
T36.7 Antifungal antibiotics, systemically used
0.000 0.996 0.004
T36.6 Rifamycins
0.000 0.996 0.004
T36.5 Aminoglycosides
0.000 0.996 0.004
T36.2 Chloramphenicol group
0.000 0.996 0.004
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.996 0.004
T41.2 Other and unspecified general anaesthetics
0.000 0.996 0.004
G24 Dystonia
0.000 0.996 0.004
N41.9 Inflammatory disease of prostate, unspecified
0.000 0.996 0.004
T45.5 Anticoagulants
0.000 0.996 0.004
G95.1 Vascular myelopathies
0.000 0.996 0.004
S62.5 Fracture of thumb
0.004 0.996 0.000
E73.8 Other lactose intolerance
0.000 0.996 0.003
E73.1 Secondary lactase deficiency
0.000 0.996 0.003
E73.0 Congenital lactase deficiency
0.000 0.996 0.003
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.996 0.003
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.996 0.003
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.996 0.003
E74.2 Disorders of galactose metabolism
0.000 0.996 0.003
E74.1 Disorders of fructose metabolism
0.000 0.996 0.003
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.996 0.004
M13.90 Arthritis, unspecified (Multiple sites)
0.000 0.996 0.004
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec
0.004 0.996 0.000
N02.7 Diffuse crescentic glomerulonephritis
0.000 0.996 0.003
N02.6 Dense deposit disease
0.000 0.996 0.003
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.996 0.003
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.996 0.003
N02.1 Focal and segmental glomerular lesions
0.000 0.996 0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.996 0.003
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.997 0.003
M00.91 Pyogenic arthritis, unspecified (Shoulder region)
0.000 0.997 0.003
H11.8 Other specified disorders of conjunctiva
0.003 0.997 0.000
M00.9 Pyogenic arthritis, unspecified
0.000 0.997 0.003
G63 Polyneuropathy in diseases classified elsewhere
0.000 0.997 0.003
M00.96 Pyogenic arthritis, unspecified (Lower leg)
0.000 0.997 0.003
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other
0.003 0.997 0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot
0.003 0.997 0.000
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg
0.003 0.997 0.000
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh
0.003 0.997 0.000
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm
0.003 0.997 0.000
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm
0.003 0.997 0.000
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region
0.003 0.997 0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites
0.003 0.997 0.000
E74.0 Glycogen storage disease
0.000 0.997 0.003
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.997 0.003
K74.3 Primary biliary cirrhosis
0.000 0.997 0.003
L40.9 Psoriasis, unspecified
0.000 0.997 0.003
G24.8 Other dystonia
0.000 0.997 0.003
G31.0 Circumscribed brain atrophy
0.000 0.997 0.003
L43 Lichen planus
0.003 0.997 0.000
D73.0 Hyposplenism
0.000 0.997 0.003
M47.9 Spondylosis, unspecified
0.000 0.997 0.003
S22.20 Fracture of sternum (closed)
0.003 0.997 0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.997 0.003
N02.0 Minor glomerular abnormality
0.000 0.997 0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.997 0.003
D73 Diseases of spleen
0.000 0.997 0.003
M00.90 Pyogenic arthritis, unspecified (Multiple sites)
0.000 0.997 0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.997 0.003
G32 Other degenerative disorders of nervous system in diseases classified elsewhere
0.000 0.997 0.003
E04.8 Other specified non-toxic goitre
0.003 0.997 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.997 0.003
T46.7 Peripheral vasodilators
0.000 0.997 0.003
K74.5 Biliary cirrhosis, unspecified
0.000 0.997 0.003
E89.4 Postprocedural ovarian failure
0.000 0.997 0.003
N04.9 Unspecified
0.000 0.997 0.003
T45.0 Antiallergic and antiemetic drugs
0.000 0.997 0.003
G31.2 Degeneration of nervous system due to alcohol
0.000 0.997 0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.997 0.003
G24.5 Blepharospasm
0.000 0.997 0.003
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.997 0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.997 0.003
N02.2 Diffuse membranous glomerulonephritis
0.000 0.997 0.003
G24.4 Idiopathic orofacial dystonia
0.000 0.997 0.003
G24.2 Idiopathic nonfamilial dystonia
0.000 0.997 0.003
G24.1 Idiopathic familial dystonia
0.000 0.997 0.003
M00.99 Pyogenic arthritis, unspecified (Site unspecified)
0.000 0.997 0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.997 0.003
Z51.1 Chemotherapy session for neoplasm
0.000 0.997 0.003
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.997 0.003
E89.5 Postprocedural testicular hypofunction
0.000 0.997 0.003
E89.1 Postprocedural hypoinsulinaemia
0.000 0.997 0.003
M47.82 Other spondylosis (Cervical region)
0.000 0.997 0.003
K31.7 Polyp of stomach and duodenum
0.000 0.997 0.003
K75 Other inflammatory liver diseases
0.003 0.997 0.000
M00.97 Pyogenic arthritis, unspecified (Ankle and foot)
0.000 0.997 0.003
M00.95 Pyogenic arthritis, unspecified (Pelvic region and thigh)
0.000 0.997 0.003
H11.0 Pterygium
0.003 0.997 0.000
T43.2 Other and unspecified antidepressants
0.000 0.997 0.003
M47.95 Spondylosis, unspecified (Thoracolumbar region)
0.000 0.997 0.003
M47.94 Spondylosis, unspecified (Thoracic region)
0.000 0.997 0.003
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.997 0.003
D86.9 Sarcoidosis, unspecified
0.003 0.997 0.000
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.997 0.003
M24.4 Recurrent dislocation and subluxation of joint
0.003 0.997 0.000
L43.8 Other lichen planus
0.003 0.997 0.000
N04 Nephrotic syndrome
0.000 0.997 0.003
M00.98 Pyogenic arthritis, unspecified (Other)
0.000 0.997 0.003
D73.9 Disease of spleen, unspecified
0.000 0.997 0.003
H11.1 Conjunctival degenerations and deposits
0.003 0.997 0.000
T36.0 Penicillins
0.000 0.997 0.002
G63.8 Polyneuropathy in other diseases classified elsewhere
0.000 0.997 0.003
G63.6 Polyneuropathy in other musculoskeletal disorders
0.000 0.997 0.003
G63.5 Polyneuropathy in systemic connective tissue disorders
0.000 0.997 0.003
G63.4 Polyneuropathy in nutritional deficiency
0.000 0.997 0.003
G63.3 Polyneuropathy in other endocrine and metabolic diseases
0.000 0.997 0.003
G63.1 Polyneuropathy in neoplastic disease
0.000 0.997 0.003
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere
0.000 0.997 0.003
D73.3 Abscess of spleen
0.000 0.997 0.003
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.997 0.002
K74.0 Hepatic fibrosis
0.000 0.997 0.003
Z53.0 Procedure not carried out because of contraindication
0.000 0.997 0.003
M00.94 Pyogenic arthritis, unspecified (Hand)
0.000 0.997 0.003
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.003 0.997 0.000
G24.0 Drug-induced dystonia
0.000 0.997 0.002
E83.5 Disorders of calcium metabolism
0.000 0.997 0.002
M00.93 Pyogenic arthritis, unspecified (Forearm)
0.000 0.997 0.002
L43.3 Subacute (active) lichen planus
0.002 0.997 0.000
L43.2 Lichenoid drug reaction
0.002 0.997 0.000
L43.1 Bullous lichen planus
0.002 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.